A biocompatible poly(amidoamine) (PAMAM) dendrimer octa-substituted with α-cyclodextrin towards the controlled release of doxorubicin hydrochloride from its ferrocenyl prodrug

This journal is © The Royal Society of Chemistry..

Facile and efficient methods for the synthesis of the first poly(aminodamine) PAMAM G1.0 dendrimer octa-substituted with α-cyclodextrin and a novel ferrocenyl prodrug of doxorubicin hydrochloride are developed. This vector is non-toxic and can bind the designed ferrocenyl prodrug. It also shows a controlled drug release profile and high cytotoxicity against breast cancer cells (MCF-7), as elucidated by the in vitro biological studies performed with an innovative cell-on-a-chip microfluidic system.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

RSC advances - 10(2020), 39 vom: 16. Juni, Seite 23440-23445

Sprache:

Englisch

Beteiligte Personen:

Kasprzak, Artur [VerfasserIn]
Dabrowski, Bartłomiej [VerfasserIn]
Zuchowska, Agnieszka [VerfasserIn]

Links:

Volltext

Themen:

Journal Article

Anmerkungen:

Date Revised 16.07.2022

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1039/d0ra03694c

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM340488794